Italmobiliare S.p.A. (0RP4.L) Bundle
Curious how Italmobiliare S.p.A.'s 2024 results reshape the investment picture? The group posted consolidated revenue of €701.4 million in 2024, up 19.7% from €586.2 million in 2023, while consolidated EBITDA surged to €157.2 million-a 58.5% increase that lifted the EBITDA margin to 22.4%; key portfolio drivers include Industrial Portfolio Companies at €1.562 billion (+8.6%), Caffè Borbone at €334.5 million (+11.4%) with €67.5 million EBITDA, Officina Profumo-Farmaceutica di Santa Maria Novella at €70 million (+24.6%) and CDS-Casa della Salute at €63.2 million (+48%), all against a backdrop of a positive net financial position of €273.8 million, equity of €1.3729 billion, dividends distributed of €126.9 million, a NAV per share rising to €52.4 in 2024 (NAV per share €52.2 as of Sept 2025 reflecting a ~42% discount) and a market capitalization near €1.04 billion-read on for a chapter-by-chapter breakdown of liquidity, valuation, risks and growth opportunities.
Italmobiliare S.p.A. (0RP4.L) - Revenue Analysis
Italmobiliare S.p.A. reported robust top-line growth in 2024, driven by strong performance across its industrial portfolio and several standout subsidiaries. Consolidated revenue rose sharply year-on-year, while key portfolio companies delivered double-digit gains that underpinned group momentum.
- Consolidated revenue (2024): €701.4 million (+19.7% vs. €586.2 million in 2023)
- Industrial Portfolio Companies revenue (2024): €1,562.0 million (+8.6% vs. €1,438.0 million in 2023)
| Entity | 2023 Revenue (€m) | 2024 Revenue (€m) | YoY Change |
|---|---|---|---|
| Italmobiliare S.p.A. (Consolidated) | 586.2 | 701.4 | +19.7% |
| Industrial Portfolio Companies (aggregate) | 1,438.0 | 1,562.0 | +8.6% |
| Caffè Borbone | 300.2 | 334.5 | +11.4% |
| Officina Profumo-Farmaceutica di Santa Maria Novella | 56.1 | 70.0 | +24.6% |
| CDS - Casa della Salute | 42.7 | 63.2 | +48.0% |
| SIDI | 23.8 | 31.7 | +33.1% |
Drivers and notable dynamics:
- Portfolio breadth: Growth was broad-based across consumer (Caffè Borbone), luxury/heritage (Officina Profumo-Farmaceutica di Santa Maria Novella), healthcare (CDS), and industrial (SIDI).
- High-growth contributors: CDS recorded the largest percentage increase (+48.0%), indicating accelerating demand in health-related services; OP-FSM's 24.6% rise reflects strong premiumization and international expansion.
- Scale and stability: Caffè Borbone remains a major revenue engine at €334.5m, providing scale and recurring cash flow for the group.
For strategic context on group direction and priorities that support revenue growth, see Mission Statement, Vision, & Core Values (2026) of Italmobiliare S.p.A.
Italmobiliare S.p.A. (0RP4.L) Profitability Metrics
- Consolidated momentum: EBITDA rose to €157.2 million in 2024, up 58.5% from €99.2 million in 2023; EBITDA margin expanded to 22.4% (from 16.9% in 2023).
- Key drivers: strong contribution from Caffè Borbone, margin improvement across selected subsidiaries, and turnaround at SIDI.
- Notable segment performances and YoY movements reflect operational leverage and cost control initiatives.
| Item | 2023 | 2024 | Change / Notes |
|---|---|---|---|
| Consolidated EBITDA | €99.2 million | €157.2 million | +58.5%; EBITDA margin 16.9% → 22.4% |
| Caffè Borbone EBITDA | - | €67.5 million | EBITDA margin 20.2% (2024) |
| Officina Profumo‑Farmaceutica di Santa Maria Novella EBITDA | - | €19.2 million | +22.1% YoY (2024) |
| CDS‑Casa della Salute EBITDA | - | €7.5 million | +48% YoY (2024) |
| SIDI EBITDA | Negative (2023) | €0.4 million | Turnaround to positive EBITDA in 2024 |
- Margin expansion: consolidated margin improvement to 22.4% indicates higher profitability per euro of revenue and effective cost absorption.
- Segment concentration: Caffè Borbone is a major EBITDA contributor (€67.5m), implying group-level exposure to its operational performance.
- Recovery and growth pockets: Officina and CDS showing double-digit EBITDA growth; SIDI moving from loss to positive EBITDA supports de-risking narrative.
Italmobiliare S.p.A. (0RP4.L) - Debt vs. Equity Structure
Italmobiliare enters 2025 with a capital structure characterized by rising equity, a persistent positive net financial position and a shareholder-focused distribution policy. Key headline figures for investors (year-end 2024 vs. 2023) are summarized below.| Metric | 2024 | 2023 |
|---|---|---|
| Shareholders' Equity | €1,372.9 million | €1,335.5 million |
| Net Financial Position (NFP) | +€273.8 million | +€273.8 million |
| Dividends Distributed (during 2024) | €126.9 million | - |
| NAV per Share | €52.4 | €49.3 |
| Market Capitalization (May 9, 2025) | €1.04 billion | - |
| Investment Approach | Conservative; significant allocation to low‑risk financial instruments | |
- Equity growth: +€37.4 million year-over-year (2023→2024), signaling retained earnings and/or revaluations supporting the balance sheet.
- Positive NFP of €273.8 million (unchanged) indicates a net cash position rather than net indebtedness, reducing financial leverage risk.
- Dividend commitment: €126.9 million paid in 2024, reflecting strong cash distribution discipline despite a conservative asset mix.
- NAV per share rose to €52.4 from €49.3, narrowing the gap to market cap and suggesting potential upside for NAV‑sensitive investors.
- With positive NFP, Italmobiliare's balance sheet is biased toward equity and liquidity rather than debt - supporting resilience in downturns.
- The company's conservative allocation to low‑risk instruments preserves capital but may temper portfolio yield and growth in higher-return environments.
- Market cap (~€1.04bn) vs. shareholders' equity (€1.373bn) implies a price-to-book relationship below 1.0, an important valuation lens for value investors.
Italmobiliare S.p.A. (0RP4.L) - Liquidity and Solvency
Italmobiliare S.p.A. maintains a solid liquidity and solvency profile at the start of 2025, supported by a strong equity base, a stable net financial position, recurring dividend receipts and an active cash-return policy to shareholders. Key metrics through March 31, 2025 and year-to-date flows through September 2025 illustrate capacity to fund strategic investments while returning capital to investors.- Liquidity and financial assets (cash, cash equivalents, short-term securities): €203 million as of March 31, 2025 (a decrease of €67 million year-to-date).
- Net financial position: positive €273.8 million at March 31, 2025 - effectively unchanged from December 31, 2024.
- Quarterly cash inflows from dividends: €7.5 million in Q1 2025.
- Equity: increased by €37.4 million to €1,372.9 million as of March 31, 2025.
- Dividends distributed year-to-date: €38 million as of September 2025, reflecting a stable dividend policy.
| Metric | Value | Period / Note |
|---|---|---|
| Liquidity & financial assets | €203.0 million | As of 31-Mar-2025 (-€67m YTD) |
| Net financial position | €273.8 million (positive) | 31-Mar-2025; in line with 31-Dec-2024 |
| Equity | €1,372.9 million | Increase of €37.4m vs prior |
| Dividends received (cash) | €7.5 million | Q1 2025 |
| Dividends distributed (YTD) | €38.0 million | As of Sep 2025 |
| Primary uses of liquidity | Strategic investments, shareholder returns | Ongoing |
Italmobiliare S.p.A. (0RP4.L) - Valuation Analysis
Italmobiliare's market and intrinsic metrics as of mid‑2025 show a clear dislocation between quoted equity value and estimated asset value, driven by portfolio composition, liquidity characteristics and investor perception of holding‑company discounts.| Metric | Value | Date / Notes |
|---|---|---|
| NAV per share | €52.2 | As of September 2025 |
| Market capitalization | ≈ €1.04 billion | As of May 9, 2025 |
| Discount to NAV | 42% | Computed from NAV per share vs. market price |
| Price‑to‑Sales (P/S) | 1.92 | Indicates moderate valuation vs. revenue |
| Investment approach | Conservative; large allocation to low‑risk instruments | Portfolio tilt reduces volatility but can widen discount |
| Strategic focus | Italian mid‑sized companies with international potential | Private portfolio emphasis since 2017 has driven NAV growth |
- NAV discount drivers: holding‑company structure, reduced free float, liquidity premium for underlying assets, and market skepticism on realizable value of private holdings.
- Valuation implication of P/S = 1.92: implies moderate revenue coverage by market cap; attractive only if revenue growth or margin expansion is expected from portfolio companies.
- Risk/return tradeoff: conservative asset mix lowers downside volatility but can limit re‑rating catalysts unless governance, buybacks or asset rotations occur.
- Strategic strengths: focused dealflow into Italian mid‑caps with international reach, expertise in active stewardship of private portfolio companies, and a track record of NAV accretion since the 2017 pivot.
- Key investors' considerations: potential catalyst paths include NAV‑accretive exits, dividend policy changes, share buybacks, or narrowing of the holding‑company discount via improved market liquidity.
Italmobiliare S.p.A. (0RP4.L) - Risk Factors
Italmobiliare S.p.A. operates as a diversified holding with exposures across consumer goods (Caffè Borbone), luxury & cosmetics (Officina Profumo-Farmaceutica di Santa Maria Novella), healthcare (CDS - Casa della Salute), real estate, and financial investments. Key risk vectors that can materially affect cash flows, margins and valuation include macro inflation, geopolitical tensions, supply chain disruptions, commodity price volatility, regulatory shifts, currency moves and sector competition.- Macro / inflation: Persistent headline inflation in Eurozone (historically ranging 2-10% in stressed periods) increases operating costs (wages, energy, transport) and compresses consumer discretionary spending, pressuring group EBITDA margins.
- Geopolitical risk: Tensions in Eastern Europe, the Middle East or trade disruptions can raise logistics costs, impact export markets and increase insurance and financing premiums.
| Risk Category | Primary Exposure | Potential Financial Impact | Time Horizon |
|---|---|---|---|
| Inflation | All subsidiaries (energy, labor) | EBITDA margin compression of 100-300 bps under sustained 3-6% inflation | 6-24 months |
| Geopolitical tensions | Logistics, export sales | Increased freight & insurance costs; revenue volatility in affected markets (up to 5-10% sales impact) | Short to medium |
| Supply chain disruption | Caffè Borbone & manufacturing partners | Higher input and logistic costs; reported margin squeeze in 2022-2023 for Caffè Borbone | Immediate to 12 months |
| Commodity price volatility | Coffee beans, packaging materials | Raw material cost swings can change gross margin by several pct points; arabica/robusta price shocks can add €€€ to COGS | Variable |
| Regulatory changes | CDS - healthcare services | Reimbursement and compliance changes can reduce revenue or increase capex/opex | Medium term |
| FX fluctuations | Exports, foreign subsidiaries | Reported net income volatility; translation and transaction losses possible | Ongoing |
| Competitive pressure | Luxury & cosmetics (Santa Maria Novella) | Market share and pricing pressure; margin dilution if discounting or higher marketing spend required | Ongoing |
- Supply chain & Caffè Borbone specifics: recent periods of logistics congestion and tighter container capacity increased landed costs for coffee and packaging. Management commentary has cited margin pressure in the specialty coffee division tied to freight rate spikes and scarce packaging availability.
- Raw material volatility: Global coffee benchmarks (arabica and robusta) have historically moved ±20-40% across tight-supply cycles; a similar move would materially affect Caffè Borbone gross margin unless fully hedged.
- Healthcare regulation: Changes in regional/national reimbursement or licensing for private clinics can reduce utilization rates at CDS-Casa della Salute or require additional compliance spend.
- Currency: A stronger euro vs. USD/BRL or other local currencies can reduce translated EBITDA from export-driven businesses; exposure should be monitored against reported net financial items.
- Luxury market competition: Brand positioning for Officina Profumo-Farmaceutica di Santa Maria Novella faces competition from established luxury houses-sustained market share erosion would force higher marketing investment or discounting.
- EBITDA margin sensitivity: estimate 100 bps change per ~€5-10m swing in operating costs for medium-sized subsidiaries (example sizing dependant on segment).
- Commodity sensitivity: a 25% rise in coffee bean prices could increase COGS for the coffee business by mid-single digit % of revenue without hedging.
- FX sensitivity: a 5% sustained EUR appreciation may reduce consolidated net income from foreign operations by a similar percentage depending on net exposure.
- Supply chain lead times: increases from 4-6 weeks to 10-12 weeks materially increase working capital and inventory holding costs.
Italmobiliare S.p.A. (0RP4.L) Growth Opportunities
Italmobiliare S.p.A. (0RP4.L) is positioning its diversified portfolio to capture growth through targeted capital deployment, international expansion, renewable energy rollout and operational support to industrial subsidiaries. The following sections break down the main growth levers, the near-term quantitative targets and the operational levers management is prioritizing.- Portfolio development: continued allocation toward Italian industrial leaders across manufacturing, consumer goods and energy segments.
- Operational support: strengthening production-chain oversight and international distribution capabilities for portfolio companies.
- Capital allocation: mix of organic investment and selective M&A to accelerate scale.
- International expansion: focused push into North American retail and foodservice channels for Caffè Borbone.
- Renewables investment: expansion of Italgen photovoltaic capacity and related green energy projects.
- Innovation & sustainability: funding R&D, digitalization and ESG upgrades across holdings.
Capital and allocation targets (illustrative short-term plan)
| Area | Planned 12-36 month allocation | Primary objective | Target metric |
|---|---|---|---|
| Organic growth funding | €50-100 million | Capex & product development in portfolio companies | Revenue growth +6-10% p.a. at supported subsidiaries |
| M&A / Inorganic plays | €80-200 million (opportunistic) | Strategic acquisitions to consolidate niches | +3-5pp EBITDA margin accretion |
| International expansion (Caffè Borbone) | €20-60 million | Expand US distribution, marketing, partnerships | Double US revenues within 3 years (baseline 2023) |
| Renewables (Italgen) | €40-120 million | Photovoltaic plant development and grid connections | Add 50-150 MW capacity |
Commercial & operational levers
- Supply-chain visibility: centralized KPI dashboards and periodic audits to reduce stock-outs and working capital by an estimated 5-10% at targeted subsidiaries.
- Distribution scaling: increase direct-to-retailer penetration and e-commerce presence - aim to lift overall portfolio export share from a mid-teens percentage to above 25% over a multi-year horizon.
- Product & brand investment: top-line lift via new SKUs, private label contracts and co-branding agreements; expected uplift of 3-7% in consumer facing businesses.
- Energy optimization: integrate Italgen's generation to hedge industrial electricity costs for manufacturing assets, targeting a 2-4% reduction in consolidated energy costs.
Renewables: Italgen photovoltaic initiative
Italgen's photovoltaic program is a core growth pillar within the group's sustainability push. Planned investments and capacity targets are calibrated to create both an income stream from electricity sales and a cost-offset for industrial operations.
| Metric | Short-term target (12-24 months) | Medium-term target (36 months) |
|---|---|---|
| Installed PV capacity | 50 MW | 150 MW |
| Annual generation | ~70 GWh | ~210 GWh |
| Estimated annual EBITDA contribution | €6-10 million | €18-30 million |
| CO2 avoided | ~30 kt CO2/year | ~90 kt CO2/year |
International expansion: Caffè Borbone focus
- North America: prioritize retail distribution, foodservice partnerships and digital marketing to accelerate brand recognition.
- Target metrics: achieve a low-double-digit market share in selected US metro grocery categories within 3-5 years in targeted states.
- Channel mix emphasis: blend e-commerce (30-40% of new market sales) with brick-and-mortar and B2B coffee-service agreements.
Innovation & sustainability initiatives
- Sustainability financing: green bonds or sustainability-linked loans expected to fund part of renewables and energy-efficiency projects; target blended cost of capital reduction by ~25-50 bps for financed projects.
- R&D support: centralized co-investment programs to help portfolio companies digitalize production (Industry 4.0) and develop eco-packaging solutions.
- ESG KPIs: roll-out of standardized ESG scorecards across holdings with improvement targets (e.g., reduce scope 1-2 emissions intensity by 15-25% over 3-5 years).
Near-term performance indicators investors should monitor
- Capital deployed vs. announced allocation (quarterly updates).
- Change in consolidated net debt / EBITDA ratio following M&A and renewables spending.
- Revenue contribution from international markets (US share for Caffè Borbone).
- Italgen installed capacity and realized generation vs. targets.
- ESG scorecard evolution and published emission reductions.
For context on investor composition and recent market activity, see: Exploring Italmobiliare S.p.A. Investor Profile: Who's Buying and Why?

Italmobiliare S.p.A. (0RP4.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.